Spectrum Planning & Advisory Services Inc. Crispr Therapeutics Ag Transaction History

Spectrum Planning & Advisory Services Inc.

$101 Million
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$38.62 - $72.18 $136,019 - $254,217	3,522 New	3,522 $220,000
Q2 2023 Jul 24, 2023	BUY	$43.47 - $67.77 $160,143 - $249,664	3,684 New	3,684 $206,000
Q3 2022 Oct 17, 2022	SELL	$61.1 - $83.78 $5,804 - $7,959	-95 Reduced 2.43%	3,816 $249,000
Q2 2022 Jul 15, 2022	SELL	$43.23 - $73.83 $44,699 - $76,340	-1,034 Reduced 20.91%	3,911 $238,000
Q4 2021 Jan 19, 2022	BUY	$70.09 - $111.29 $31,540 - $50,080	450 Added 10.01%	4,945 $375,000
Q3 2021 Oct 13, 2021	SELL	$110.2 - $156.64 $8,485 - $12,061	-77 Reduced 1.68%	4,495 $503,000
Q2 2021 Jul 19, 2021	SELL	$100.84 - $161.89 $10,386 - $16,674	-103 Reduced 2.2%	4,572 $740,000
Q1 2021 Apr 27, 2021	BUY	$110.72 - $210.04 $11,072 - $21,004	100 Added 2.19%	4,675 $570,000
Q4 2020 Feb 02, 2021	BUY	$79.67 - $173.23 $364,490 - $792,527	4,575 New	4,575 $700,000

Others Institutions Holding CRSP

# of Institutions

489

Shares Held

57.9M

Call Options Held

1.1M

Put Options Held

1.9M

Capital International Investors Los Angeles, CA

7.93M
Shares

$315 Million
0.07% of portfolio
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

7.5M
Shares

$298 Million
3.35% of portfolio
State Street Corp Boston, MA

2.99M
Shares

$119 Million
0.01% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.97M
Shares

$118 Million
0.1% of portfolio
Nikko Asset Management Americas, Inc.

2.97M
Shares

$118 Million
1.61% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spectrum Planning & Advisory Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Spectrum Planning & Advisory Services Inc. with notifications on news.

Account